Literature DB >> 12599216

Mast cell-mediated apoptosis of endothelial cells in vitro: a paracrine mechanism involving TNF-alpha-mediated down-regulation of bcl-2 expression.

Soili Lätti1, Markus Leskinen, Naotaka Shiota, Yenfeng Wang, Petri T Kovanen, Ken A Lindstedt.   

Abstract

Degranulated mast cells are present in the subendothelial space of eroded (de-endothelialized) coronary atheromas. Upon degranulation, mast cells secrete into the surrounding tissue an array of preformed and newly synthesized mediators, including proapoptotic molecules, such as chymase and TNF-alpha. In a co-culture system involving rat serosal mast cells and rat cardiac (microvascular) endothelial cells, we could show, by means of competitive RT-PCR, immunoblotting, immunocytochemistry, annexin staining, flow cytometry, and DNA-laddering, that stimulation of mast cells with ensuing degranulation rapidly (within 30 min) down-regulated the expression of both bcl-2 mRNA and protein, with subsequent induction of apoptosis in the endothelial cells. The major effect of bcl-2 down-regulation resided in the exocytosed granule remnants, a minor effect also being present in the granule remnant-free supernatant. No significant changes were observed in the expression levels of the pro-apoptotic protein, bax. The mast cell-mediated apoptotic effect was partially (70%) dependent on the presence of TNF-alpha and involved the translocation of cytochrome C from mitochondria into cytoplasm. These results are the first to show that one of the cell types present in the atherosclerotic plaques, namely the mast cell, by releasing both granule-remnant-bound and soluble TNF-alpha, may contribute to the erosion of atherosclerotic plaques by inducing apoptosis in adjacent endothelial cells. Published 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12599216     DOI: 10.1002/jcp.10235

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  15 in total

1.  Overexpression of Bcl-2 in vascular endothelium inhibits the microvascular lesions of diabetic retinopathy.

Authors:  Timothy S Kern; Yunpeng Du; Casey M Miller; Denise A Hatala; Leonard A Levin
Journal:  Am J Pathol       Date:  2010-04-02       Impact factor: 4.307

Review 2.  Mast cell chymase and tryptase as targets for cardiovascular and metabolic diseases.

Authors:  Aina He; Guo-Ping Shi
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

3.  Immune System in Action.

Authors:  Bettzy Stephen; Joud Hajjar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Isoflavone genistein protects human vascular endothelial cells against tumor necrosis factor-alpha-induced apoptosis through the p38beta mitogen-activated protein kinase.

Authors:  Hongwei Si; Dongmin Liu
Journal:  Apoptosis       Date:  2009-01       Impact factor: 4.677

5.  Lysophosphatidic acid triggers mast cell-driven atherosclerotic plaque destabilization by increasing vascular inflammation.

Authors:  Martine Bot; Saskia C A de Jager; Luke MacAleese; H Maxime Lagraauw; Theo J C van Berkel; Paul H A Quax; Johan Kuiper; Ron M A Heeren; Erik A L Biessen; Ilze Bot
Journal:  J Lipid Res       Date:  2013-02-10       Impact factor: 5.922

6.  Involvement of mast cells in gastritis caused by Helicobacter pylori: a potential role in epithelial cell apoptosis.

Authors:  Véronique Hofman; Sandra Lassalle; Eric Selva; Kheira Kalem; Adrien Steff; Xavier Hébuterne; Dominique Sicard; Patrick Auberger; Paul Hofman
Journal:  J Clin Pathol       Date:  2007-06       Impact factor: 3.411

7.  Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases.

Authors:  Ashish B Rajput; Dmitry A Turbin; Maggie Cu Cheang; David K Voduc; Sam Leung; Karen A Gelmon; C Blake Gilks; David G Huntsman
Journal:  Breast Cancer Res Treat       Date:  2007-03-13       Impact factor: 4.872

8.  Relationship between numerous mast cells and early follicular development in neonatal MRL/MpJ mouse ovaries.

Authors:  Teppei Nakamura; Saori Otsuka; Osamu Ichii; Yuko Sakata; Ken-Ichi Nagasaki; Yoshiharu Hashimoto; Yasuhiro Kon
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

9.  Mast cells: pivotal players in cardiovascular diseases.

Authors:  Ilze Bot; Theo J C van Berkel; Erik A L Biessen
Journal:  Curr Cardiol Rev       Date:  2008-08

Review 10.  Mast cells in vulnerable atherosclerotic plaques--a view to a kill.

Authors:  Ken A Lindstedt; Mikko I Mäyränpää; Petri T Kovanen
Journal:  J Cell Mol Med       Date:  2007 Jul-Aug       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.